Skip to main content
. Author manuscript; available in PMC: 2022 Jul 19.
Published in final edited form as: Pharm Res. 2022 Mar 3;39(7):1587–1598. doi: 10.1007/s11095-022-03218-w

Table 2.

UFR and ER of Nln Activators Obtained from Permeability Assay with MDR1-MDCK P-gp Overexpressed Cells

UFR (+CsA/−CsA) Efflux Ratio
11a 2.36 ± 0.04 8.85 ± 0.3
9d 2.31 ± 0.29 5.1 ± 0.1
10c 4.24 ± 0.7 52.98 ± 5.25